ArticleOncotarget2017

Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.

Craig T Wallington-Beddoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.